Background: Insulin analogues may be associated with fewer episodes of hypoglycemia
than conventional insulins. However, they are costly alternatives. We compared the cost …

Background: Although insulin analogues are commonly prescribed for the management of
diabetes mellitus, there is uncertainty regarding their optimal use. We conducted meta …

Background Insulin analogues have a pharmacokinetic advantage over human insulin and
are increasingly used to treat diabetes mellitus. A summary of their cost effectiveness versus …

Long-acting insulin analogues (specifically insulin glargine and insulin detemir) were
investigated for the treatment of diabetes mellitus. The authors found that long-acting insulin …

A recent meta-analysis evaluated trials of the rapid-acting analogues insulin lispro and
insulin aspart, performed before the introduction of the basal analogues, insulin glargine …

Background Short‐acting insulin analogue use for people with diabetes is still controversial,
as reflected in many scientific debates. Objectives To assess the effects of short‐acting …

This willingness-to-pay (WTP) analysis is the first study of its kind undertaken in Australia to
support an application for listing of a new drug on the Australian national formulary. The …

Aims This study assessed the cost‐effectiveness of long‐acting insulin analogues (LAIAs) vs
intermediate/long‐acting human insulin (ILAHI) for patients with type 1 diabetes (T1D) in real …

Background and objective Intensive insulin therapy improves glycosylated haemoglobin (Hb
A1C) levels and delays the onset of long-term diabetes-related complications. Current …

Background: Basal insulin analogues aim for protracted glycemic control with minimal
adverse effects. Purpose: To assess the comparative efficacy and safety of basal insulin …